What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations? medrxivpreprint UniofOxford SARSCoV2 COVID19 Vaccination Vaccine Efficacy Booster
By Shanet Susan AlexAug 2 2022Reviewed by Aimee Molineux In a recent study posted to the medRxiv* preprint server, scientists compared the effectiveness of the severe acute respiratory syndrome coronavirus 2 BNT162b2 and mRNA-1273 vaccine booster doses in England.
About the study In the current study, on account of National Health Service England, the researchers used the OpenSAFELY-TPP database to match adults who received the SARS-CoV-2 mRNA-1273 or BNT162b2 vaccine on vaccination date, age, primary vaccine course, and other factors.
Results Overall, the study results showed that during the research period, 10,139,268 people registered at a TPP practice had a COVID-19 booster shot with either mRNA-1273 or BNT162b2 , with 6,264,525, i.e., 86.5%, and 6,264,525, i.e., 87.1%, eligible for matching. Compared to mRNA-1273 booster recipients, eligible BNT162b2 booster recipients were typically more deprived, older, and more likely to have a history of clinical conditions.
Less than one in 3,800 booster recipients were hospitalized with COVID-19, and less than one in 100,000 died with COVID-19 as a contributing or underlying cause. Severe COVID-19 disease was extremely uncommon up to 12 weeks post-booster vaccination. Regardless of clinical vulnerability, age, or evidence of past infection, the relative efficacy of mRNA1273 versus BNT162b2 against COVID-19 hospitalization was comparable.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
CDC study describes safety profile of second mRNA COVID boosterThe CDC investigates the safety profile of a fourth dose of mRNA-based COVID-19 vaccines in people aged 50 years and older.
続きを読む »
Reduced severity of COVID-19 in pregnant women during the Omicron waveA new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.
続きを読む »
Is cannabidiol effective against COVID-19?Is cannabidiol effective against COVID-19? Coronavirus Disease COVID Antibodies AntiInflammatory Asthma Cannabidiol Cannabinoid Cannabis LiebertPub LMU_Muenchen
続きを読む »
Good Morning Britain's Kate Garraway gives an update on husbandHer husband has been struggling with long term health problems due to Covid-19
続きを読む »
Changes in Smoking Cessation–Related Behaviors During the COVID-19 PandemicThis cross-sectional study compares prevalence of past-year quit attempts and sales volumes of nicotine replacement therapy before vs during the COVID-19 pandemic among US adult smokers.
続きを読む »
Study finds negative impact of COVID-19 pandemic on mental health status in low and middle income countriesStudy finds negative impact of COVID-19 pandemic on mental health status in low and middle income countries medrxivpreprint Yale VUamsterdam SARSCoV2 COVID19 Pandemic MentalHealth
続きを読む »